Nishio E, Tomiyama K, Nakata H, Watanabe Y
Department of Pharmacology, National Defense Medical College, Japan.
Eur J Pharmacol. 1996 Apr 22;301(1-3):203-6. doi: 10.1016/0014-2999(96)00063-5.
Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, inhibits the synthesis of mevalonic acid. We examined the effect of lovastatin on the differentiation of the fibroblast/adipocyte cell line (3T3-L1). Lovastatin inhibits the differentiation of 3T3-L1 cells in a dose-dependent fashion. The inhibitory effect of lovastatin was partially reversed by adding exogenous mevalonic acid to the 3T3-L1 cells. Exogenous cholesterol (15 micrograms/ml) did not prevent lovastatin inhibition of adipocyte conversion. The isoprenoids, farnesol and geraniol, partially prevented lovastatin inhibition of adipocyte conversion but squalene did not prevent lovastatin inhibition of adipocyte conversion. We conclude that the inhibitory effect of lovastatin was partially due to the blockade of the pathway leading to synthesis of isoprenoids, which are downstream products of mevalonic acid.
洛伐他汀是一种3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂,可抑制甲羟戊酸的合成。我们研究了洛伐他汀对成纤维细胞/脂肪细胞系(3T3-L1)分化的影响。洛伐他汀以剂量依赖的方式抑制3T3-L1细胞的分化。通过向3T3-L1细胞中添加外源性甲羟戊酸,洛伐他汀的抑制作用部分得到逆转。外源性胆固醇(15微克/毫升)不能阻止洛伐他汀对脂肪细胞转化的抑制作用。类异戊二烯、法尼醇和香叶醇可部分阻止洛伐他汀对脂肪细胞转化的抑制作用,但角鲨烯不能阻止洛伐他汀对脂肪细胞转化的抑制作用。我们得出结论,洛伐他汀的抑制作用部分是由于导致类异戊二烯合成的途径受阻,类异戊二烯是甲羟戊酸的下游产物。